The United States Low Molecular Weight Heparin (LMWH) Market is witnessing significant growth as hospitals, healthcare providers, and pharmaceutical companies increasingly emphasize the prevention and treatment of thromboembolic disorders, including deep vein thrombosis and pulmonary embolism. Market Overview The Neuroendocrine Carcinoma Market size is expected to reach US$ 4.05 Billion by...